A brain/cerebral aneurysm (also known as an intracranial or intracerebral aneurysm) is a weak or thin spot on a blood vessel in the brain that balloons out and fills with blood. The bulging aneurysm can put pressure on a nerve or surrounding brain tissue. It may also leak or rupture, spilling blood into the surrounding tissue (called a hemorrhage). Some cerebral aneurysms, particularly those that are very small, do not bleed or cause other problems. Cerebral aneurysms can occur anywhere in the brain, but most are located along a loop of arteries that run between the underside of the brain and the base of the skull.
An important class of drug used to treat cancer patients could be used to treat brain aneurysms, according to new research published this week.
The "Stroke Belt" refers to the swath of states in the Southeast where rates of stroke death are high, and according to the Department of Health and Environmental Control, South Carolina comes in at number six for the nation's highest rates of stroke death.
The chairman of the Senate health committee on Tuesday backed new federal regulations to remove roadblocks patients can face in obtaining copies of their electronic medical records.
Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal.
In a new study, researchers report people who have experienced an aneurysm have another reason to quit smoking.
A stroke is a "brain attack" and occurs when blood supply to the brain is cut off. According to Kenneth A. Levin, M.D., Medical Director, The Valley Hospital Stroke Center, "Most strokes are caused by a blood clot that has built up on the wall of a brain artery or one that has traveled there from another part of the body (an embolic stroke or ischemic stroke).
An interest in solving complex problems, friends training to be medical doctors and his father having a stroke helped put John Asiruwa on the path to becoming a biomedical engineer.
A Louisville patient is the first to be enrolled in a national clinical trial to test a new treatment for patients who have suffered a ruptured brain aneurysm.
Codman Neuro has launched the CODMAN ENTERPRISE 2 Vascular Reconstruction Device, the latest generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils during and after the procedure.
A UT Southwestern Medical Center study to evaluate nursing protocols designed to better triage and treat stroke patients using telemedicine will be the first study using a new consortium of medical centers.
Researchers at the Translational Genomics Research Institute and Barrow Neurological Institute have for the first time identified genetic risk factors that are linked to stress-induced cardiomyopathy (SIC), a rare type of heart disease.
UT Southwestern Medical Center will be one of three national sites to pioneer U.S. testing for an implant device that stimulates the vagus nerve in stroke patients to see whether it can help restore lost arm function.
Royal Philips today announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. (Janssen).
University Hospitals (UH) Case Medical Center and Simbionix recently launched a multi-center, randomized study comparing the clinical performance of abdominal aortic aneurysm (AAA) procedures with and without prior rehearsal in a virtual environment for physicians.
Dr. Dino Terzic got lucky the other day. In his seventh and final year as a neurosurgery resident at the University of Minnesota, the 32-year-old Bosnian got to operate on a rare type of brain aneurysm that required a special approach through the patient's forehead. As Terzic prepared to slice into the patient's scalp, he was asked if he'd ever seen this type of flaw in an artery, which occurs in just 2 to 3 percent of aneurysm cases. "On a video," Terzic replied with a chuckle. Terzic's hands-on experience shows why the nation's medical schools are beset by a nagging controversy over rules that limit the number of hours residents can work (Dan Browning, 10/8).
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company's PulseRider® in Europe, the Middle East and Africa.
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company’s PulseRider in Europe, the Middle East and Africa.
After Susan Wakulich was told she had an aneurysm, she figured an invasive brain surgery and lengthy recovery lay ahead of her.
Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25. This next-generation flow diversion device received CE Mark earlier this year.
About 1 percent of adults report they have experienced headaches associated with sexual activity, and that such headaches can be severe.